JP4509113B2 - アフェレーシス装置 - Google Patents
アフェレーシス装置 Download PDFInfo
- Publication number
- JP4509113B2 JP4509113B2 JP2006525566A JP2006525566A JP4509113B2 JP 4509113 B2 JP4509113 B2 JP 4509113B2 JP 2006525566 A JP2006525566 A JP 2006525566A JP 2006525566 A JP2006525566 A JP 2006525566A JP 4509113 B2 JP4509113 B2 JP 4509113B2
- Authority
- JP
- Japan
- Prior art keywords
- app
- column
- binding
- peptide
- apheresis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0144403A AT413336B (de) | 2003-09-12 | 2003-09-12 | Apherese-vorrichtung |
| PCT/AT2004/000311 WO2005025651A1 (de) | 2003-09-12 | 2004-09-13 | Apherese-vorrichtung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007504863A JP2007504863A (ja) | 2007-03-08 |
| JP2007504863A5 JP2007504863A5 (cg-RX-API-DMAC7.html) | 2010-03-25 |
| JP4509113B2 true JP4509113B2 (ja) | 2010-07-21 |
Family
ID=34280361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525566A Expired - Fee Related JP4509113B2 (ja) | 2003-09-12 | 2004-09-13 | アフェレーシス装置 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7935252B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1663347B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4509113B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100556472C (cg-RX-API-DMAC7.html) |
| AT (2) | AT413336B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004271651B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2538305C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1107911T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE502004005851D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1663347T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2298789T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20080090T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1663347T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1663347E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005025651A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5432923B2 (ja) * | 2008-12-22 | 2014-03-05 | 学校法人藤田学園 | Aβ除去材、Aβ除去器及びAβ除去システム |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| AT501621A1 (de) * | 2005-03-15 | 2006-10-15 | Mattner Frank Dr | Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP2237804B1 (en) * | 2007-12-21 | 2013-04-10 | GE Healthcare Bio-Sciences AB | Method for sterilization of chemically activated solid support materials |
| US20100030196A1 (en) * | 2008-07-29 | 2010-02-04 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
| RS53496B1 (sr) | 2011-10-04 | 2015-02-27 | Affiris Ag | POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU |
| US9717841B2 (en) | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| EP3166660B1 (en) * | 2014-07-10 | 2017-12-13 | Affiris AG | Substances and methods for the use in prevention and/or treatment in huntington's disease |
| JP6876601B2 (ja) | 2014-07-10 | 2021-05-26 | アフィリス・アクチェンゲゼルシャフトAffiris Ag | ハンチントン病の予防および/または処置における使用のための物質および方法 |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| GB201904810D0 (en) * | 2019-04-05 | 2019-05-22 | Cynapsedx Ltd | The treatment of protein aggregation diseases |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57103649A (en) * | 1980-12-18 | 1982-06-28 | Asahi Chemical Ind | Sterilized gamma-globulin fixing column |
| US4770774A (en) * | 1985-09-19 | 1988-09-13 | Toray Industries, Inc. | Column for removing β2 -microglobulin |
| DE3880647T2 (de) * | 1987-11-20 | 1993-11-18 | Kanegafuchi Chemical Ind | Sorbentmittel für Serum-Amyloid-Proteine. |
| US5216127A (en) * | 1987-11-20 | 1993-06-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent for serum amyloid protein |
| JPH01171638A (ja) * | 1987-12-25 | 1989-07-06 | Kanegafuchi Chem Ind Co Ltd | 血清アミロイドa蛋白用吸着体 |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| JPH06104122A (ja) | 1992-09-21 | 1994-04-15 | Matsushita Electric Ind Co Ltd | ロータリートランス |
| AU691297B2 (en) * | 1994-05-13 | 1998-05-14 | Miltenyi Biotec Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| DE19515554C2 (de) * | 1995-04-27 | 1999-06-17 | Braun Melsungen Ag | Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma |
| US5868936A (en) * | 1996-06-20 | 1999-02-09 | Baxter International Inc. | Affinity membrane system and method of using same |
| US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| EA006606B1 (ru) | 2000-02-24 | 2006-02-24 | Вашингтон Юниверсити | Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения |
| TWI238251B (en) * | 2000-07-13 | 2005-08-21 | Anawrhta Biotech Co Ltd | In-vitro adsorbing device using immunity |
| US20050227941A1 (en) * | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| AU2003303198A1 (en) * | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
-
2003
- 2003-09-12 AT AT0144403A patent/AT413336B/de not_active IP Right Cessation
-
2004
- 2004-09-13 PL PL04761033T patent/PL1663347T3/pl unknown
- 2004-09-13 PT PT04761033T patent/PT1663347E/pt unknown
- 2004-09-13 DK DK04761033T patent/DK1663347T3/da active
- 2004-09-13 US US10/571,469 patent/US7935252B2/en not_active Expired - Fee Related
- 2004-09-13 AU AU2004271651A patent/AU2004271651B2/en not_active Ceased
- 2004-09-13 WO PCT/AT2004/000311 patent/WO2005025651A1/de not_active Ceased
- 2004-09-13 JP JP2006525566A patent/JP4509113B2/ja not_active Expired - Fee Related
- 2004-09-13 CA CA2538305A patent/CA2538305C/en not_active Expired - Fee Related
- 2004-09-13 AT AT04761033T patent/ATE382383T1/de active
- 2004-09-13 CN CNB2004800303263A patent/CN100556472C/zh not_active Expired - Fee Related
- 2004-09-13 EP EP04761033A patent/EP1663347B1/de not_active Expired - Lifetime
- 2004-09-13 ES ES04761033T patent/ES2298789T3/es not_active Expired - Lifetime
- 2004-09-13 DE DE502004005851T patent/DE502004005851D1/de not_active Expired - Lifetime
- 2004-09-13 HR HR20080090T patent/HRP20080090T3/xx unknown
-
2008
- 2008-03-21 CY CY20081100330T patent/CY1107911T1/el unknown
-
2011
- 2011-03-17 US US13/049,994 patent/US20110166327A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5432923B2 (ja) * | 2008-12-22 | 2014-03-05 | 学校法人藤田学園 | Aβ除去材、Aβ除去器及びAβ除去システム |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2538305C (en) | 2011-05-24 |
| HRP20080090T3 (hr) | 2008-03-31 |
| ATA14442003A (de) | 2005-07-15 |
| US20110166327A1 (en) | 2011-07-07 |
| DE502004005851D1 (de) | 2008-02-14 |
| EP1663347A1 (de) | 2006-06-07 |
| AT413336B (de) | 2006-02-15 |
| US20070026029A1 (en) | 2007-02-01 |
| ES2298789T3 (es) | 2008-05-16 |
| EP1663347B1 (de) | 2008-01-02 |
| HK1096320A1 (zh) | 2007-06-01 |
| CA2538305A1 (en) | 2005-03-24 |
| CY1107911T1 (el) | 2013-09-04 |
| CN1867365A (zh) | 2006-11-22 |
| DK1663347T3 (da) | 2008-05-19 |
| JP2007504863A (ja) | 2007-03-08 |
| US7935252B2 (en) | 2011-05-03 |
| PT1663347E (pt) | 2008-03-28 |
| CN100556472C (zh) | 2009-11-04 |
| AU2004271651B2 (en) | 2009-08-06 |
| WO2005025651A1 (de) | 2005-03-24 |
| PL1663347T3 (pl) | 2008-06-30 |
| AU2004271651A1 (en) | 2005-03-24 |
| ATE382383T1 (de) | 2008-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110166327A1 (en) | Apheresis device | |
| KR101158600B1 (ko) | 알츠하이머병을 예방하거나 치료하기 위한 복합 치료법 및이를 위한 키트 | |
| US20060030027A1 (en) | Capture and removal of biomolecules from body fluids using partial molecular imprints | |
| US4865841A (en) | Methods and compositions for transient elimination of humoral immune antibodies | |
| Rodríguez-Rodríguez et al. | Peroxidase sensitive amplifiable probe for molecular magnetic resonance imaging of pulmonary inflammation | |
| CA3160600A1 (en) | Enhancing blood-brain barrier drug transport by targeting endogenous regulators | |
| US6080404A (en) | Materials and methods for removal of substances from fluids | |
| Spina et al. | Chemically modified poly (2‐hydroxyethyl methacrylate) cryogel for the adsorption of heparin | |
| Weiss et al. | The impact of citrate concentration on adhesion of platelets and leukocytes to adsorbents in whole blood lipoprotein apheresis | |
| US20090246203A1 (en) | Method for immunoadsorption by means of autoanitgens | |
| KR101139103B1 (ko) | 아페레시스 장치 | |
| DK2555790T3 (en) | THERAPEUTIC USE OF beta-2-microglobulin | |
| HK1096320B (zh) | 分离性输血-设备 | |
| CN101720231A (zh) | 治疗全身性红斑狼疮的肽和治疗全身性红斑狼疮的方法 | |
| US20150136701A1 (en) | Methods and devices for treating a disease state | |
| Chhipa et al. | Novel API coated catheter removes amyloid-β from plasma of patients with Alzheimer’s disease | |
| WO2007111969A2 (en) | C-reactive protein apheresis | |
| WO2005025650A1 (de) | Apherese-vorrichtung | |
| US20150291661A1 (en) | Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia | |
| US20200291101A1 (en) | Novel Treatment Method for Cockayne Syndrome | |
| JPH0611335B2 (ja) | 吸着体および除去装置 | |
| HK1243715B (en) | Preparation and composition of inter-alpha inhibitor proteins from blood | |
| HK1255676A1 (en) | THERAPEUTIC USE OF THE ß2M PROTEIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070621 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090728 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090730 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091028 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091105 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091127 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091204 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091225 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100107 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20100128 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100330 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100427 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130514 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4509113 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140514 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |